FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

32570071000036102: Clinical finding foundation reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Nov 2009. Module: SNOMED Clinical Terms Australian extension

Descriptions:

Id Description Lang Type Status Case? Module
108642091000036110 Clinical finding foundation reference set en Synonym Active Case insensitive SNOMED Clinical Terms Australian extension
108642101000036118 Clinical finding foundation reference set (foundation metadata concept) en Fully specified name Active Case insensitive SNOMED Clinical Terms Australian extension
4350871000168113 <p>Supports the recording of clinical findings and disorders in Australian e-health implementations.</p><p>This reference set can be used:<ul><li>Within implementations where use-case specific reference sets for clinical findings and disorders are yet to be developed.</li><li>As the basis for developing further use-case specific reference sets for clinical findings and disorders, through a process of constraint.</li><li>As a benchmark against which use-case specific reference sets that have been developed by the SNOMED CT-AU user community can be tested to assure that they are logical constraints of content related to clinical finding and disorders.</li></ul></p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive SNOMED Clinical Terms Australian extension


115151 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clinical finding foundation reference set Developed by Australian Digital Health Agency true Inferred relationship Some 1641902964
Clinical finding foundation reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1904103807
Clinical finding foundation reference set Is a Foundation reference sets true Inferred relationship Some
Clinical finding foundation reference set Is a Attribute value type false Inferred relationship Some
Clinical finding foundation reference set Is a Simple type reference set true Inferred relationship Some

Members
3,3'-diiodothyronine level above reference range
3,3'-diiodothyronine level below reference range
3,3'-diiodothyronine within reference range
3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency
HMG COA reductase inhibitor adverse reaction
3-Hydroxyisobutyric aciduria
3-Ketoacyl-CoA triolase deficiency
3-Methylglutaconic aciduria
3-Methylglutaconic aciduria type 1
3-Methylglutaconic aciduria type 2
3-Methylglutaconic aciduria type 3
3-Methylglutaconic aciduria type 4
3-Methylglutaconic aciduria with normal 3-methylglutaconyl-CoA hydratase activity
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency
3-Phosphoglycerate dehydrogenase deficiency
3-methylglutaconic aciduria type 5
3-methylglutaconic aciduria type 7
3-methylglutaconic aciduria type 8
3-methylglutaconic aciduria type 9
3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome
3-phosphoglycerate dehydrogenase deficiency infantile form
3-phosphoglycerate dehydrogenase deficiency juvenile form
3.5 year examination abnormal - for observation
3.5 year examination abnormal - on treatment
3.5 year examination abnormal - referred
3.5 year examination normal
3/60 visual acuity of left eye
3/60 visual acuity of right eye
30 gram fat diet
3p partial monosomy syndrome
3p partial trisomy syndrome
3p25.3 deletion syndrome
3q partial trisomy syndrome
3q13 microdeletion syndrome
3q26 microduplication syndrome
3q26q27 microdeletion syndrome
3q27.3 microdeletion syndrome
3q29 microdeletion syndrome
4 level of presenting part in relation to ischial spines
4 o'clock position on mammogram
4 point gait
4+ pitting oedema
DNOC causing toxic effect
4-Hydroxyphenylpyruvate dioxygenase deficiency
4-aminopyridine poisoning
4-quinolones adverse reaction
4.5 year examination abnormal - for observation
4.5 year examination abnormal - on treatment
4.5 year examination abnormal - referred
4.5 year examination normal
4/60 corrected visual acuity of left eye
4/60 corrected visual acuity of right eye
46 XY disorder of sex development due to maternal ingestion of oestrogen
46,XX androgen-induced disorder of sex development due to maternal adrenal hyperplasia
46,XX androgen-induced disorder of sex development of iatrogenic maternal origin
46,XX disorder of sex development
46,XX disorder of sex development caused by synthetic oral diethylstilbestrol
46,XX disorder of sex development due to synthetic oral progestogen
46,XX disorder of sex development caused by testosterone and/or testosterone derivative
46,XX disorder of sex development due to maternal Krukenberg neoplasm
46,XX disorder of sex development due to maternal adrenal neoplasm
46,XX disorder of sex development due to maternal androluteoma
46,XX disorder of sex development due to maternal arrhenoblastoma
46,XX disorder of sex development with anorectal anomalies syndrome
46,XX disorder of sex development with skeletal anomalies syndrome
46,XX ovarian dysgenesis, short stature syndrome
46,XX ovotesticular disorder of sex development
46,XX testicular disorder of sex development
46,XY disorder of sex development
46,XY disorder of sex development due to environmental chemical exposure
46,XY disorder of sex development due to isolated 17,20-lyase deficiency
46,XY disorder of sex development due to maternal ingestion of progestogen
46,XY disorder of sex development, adrenal insufficiency due to CYP11A1 deficiency
46,XY gonadal dysgenesis, motor and sensory neuropathy syndrome
46,XY ovotesticular disorder of sex development
46,XY partial gonadal dysgenesis
48,XYYY syndrome
49,XXXYY syndrome
49,XYYYY syndrome
4H leucodystrophy
4p partial monosomy syndrome
4p partial trisomy syndrome
4p16.3 microduplication syndrome
4q partial monosomy syndrome
4q partial trisomy syndrome
4q21 microdeletion syndrome
4q25 proximal deletion syndrome
5 level of presenting part in relation to ischial spines
5 o'clock position on mammogram
5,10-Methylenetetrahydrofolate reductase deficiency
5-HT3-receptor antagonist adverse reaction
5-HT3-receptor antagonist overdose
5-HT3-receptor antagonist poisoning
5-Oxoprolinase deficiency
5-amino-4-imidazole carboxamide ribosiduria
5-aminosalicylic acid adverse reaction
5-aminosalicylic acid overdose
5-aminosalicylic acid poisoning
5-HT secreting neuroendocrine tumour
5/60 corrected visual acuity of left eye
5/60 corrected visual acuity of right eye

Start Previous Page 3 of 1152 Next End


Reference Sets

Reference set descriptor

Back to Start